Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000879407-25-000013
Filing Date
2025-10-10
Accepted
2025-10-10 16:02:42
Documents
16
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-K/A arwr-20240930.htm   iXBRL 10-K/A 637379
2 EX-31.1 arwr-20240930xex311.htm EX-31.1 4048
3 EX-31.2 arwr-20240930xex312.htm EX-31.2 4055
7 GRAPHIC arwr-20240930_g1.jpg GRAPHIC 89917
  Complete submission text file 0000879407-25-000013.txt   1380636

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20240930.xsd EX-101.SCH 1941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20240930_lab.xml EX-101.LAB 135465
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20240930_pre.xml EX-101.PRE 72825
18 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20240930_htm.xml XML 7463
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-38042 | Film No.: 251388088
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)